We are live on !
Find out more
Persistent Asset Partners Portfolio holdings
AUM
$362M
Turnover
58.72%
1-Year Est. Return
191.92%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+191.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
(+7.9%)
Cap. Flow
+$7.44M
Cap. Flow % of AUM
Cap. Flow %
5.12%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75
Avg Time Held
Equity + Options
0.2
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$6.93M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.78M |
| 3 |
UnitedHealth
UNH
|
+$3.65M |
| 4 |
CVS Health
CVS
|
+$3.53M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$3.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$4.91M |
| 2 |
Encompass Health
EHC
|
+$3.58M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$3.43M |
| 4 |
Amgen
AMGN
|
+$3.35M |
| 5 |
Eli Lilly
LLY
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.9% |
| 2 | Financials | 13.82% |
| 3 | Miscellaneous | 11.7% |
| 4 | Technology | 6.61% |
| 5 | Consumer Discretionary | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Centene
CNC
$35.3B
| $8.19M | 5.63% |
+229,544
| New | +$6.93M |
2025 Q3
0 quarters
|
|
|
2
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
| $4.82M | 3.31% |
+50,000
| New | +$4.78M |
2025 Q3
0 quarters
|
|
|
3
UnitedHealth
UNH
$365B
| $4.17M | 2.86% |
+12,063
| New | +$3.65M |
2025 Q3
0 quarters
|
|
|
4
Regeneron Pharmaceuticals
REGN
$98.8B
| $3.89M | 2.67% |
6,911
+5,602
| +428% | +$3.17M |
2025 Q1
2 quarters
|
|
|
5
CVS Health
CVS
$114B
| $3.89M | 2.67% |
+51,542
| New | +$3.53M |
2025 Q3
0 quarters
|
|
6
Nebius Group N.V.
NBIS
$33.9B
| $3.37M | 2.31% |
+30,000
| New | +$2.08M |
2025 Q3
0 quarters
|
|
7
Pinduoduo
PDD
$112B
| $2.89M | 1.99% |
+21,855
| New | +$2.59M |
2025 Q3
0 quarters
|
|
|
8
iShares Bitcoin Trust
IBIT
$54.2B
| $2.87M | 1.97% |
44,200
-52,800
| -54% | -$3.43M |
2025 Q1
2 quarters
|
|
9
DELISTED
Soleno Therapeutics
SLNO
| $2.79M | 1.92% |
41,259
-24,060
| -37% | -$1.78M |
2024 Q4
3 quarters
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.1B
| $2.65M | 1.82% |
48,866
+4,602
| +10% | +$263K |
2024 Q4
3 quarters
|
|
11
Labcorp
LH
$30.1B
| $2.58M | 1.77% |
8,994
+4,260
| +90% | +$1.14M |
2025 Q2
1 quarter
|
|
12
Elevance Health
ELV
$92.8B
| $2.52M | 1.73% |
+7,806
| New | +$2.43M |
2025 Q3
0 quarters
|
|
13
Healthcare Services Group
HCSG
$1.68B
| $2.48M | 1.7% |
+147,367
| New | +$2.19M |
2025 Q3
0 quarters
|
|
14
Quest Diagnostics
DGX
$28.6B
| $2.3M | 1.58% |
12,081
+4,074
| +51% | +$723K |
2025 Q1
2 quarters
|
|
15
BrightSpring Health Services
BTSG
$14.2B
| $2.25M | 1.55% |
+76,060
| New | +$1.77M |
2025 Q3
0 quarters
|
|
16
NexGen Energy
NXE
$5.34B
| $2.23M | 1.53% |
249,352
-28,730
| -10% | -$212K |
2024 Q4
3 quarters
|
|
17
Alignment Healthcare
ALHC
$1.54B
| $2.21M | 1.52% |
126,929
-100,960
| -44% | -$1.5M |
2024 Q4
3 quarters
|
|
18
NVIDIA
NVDA
$3.93T
| $2.17M | 1.49% |
+11,614
| New | +$2.02M |
2025 Q3
0 quarters
|
|
19
Pennant Group
PNTG
$1.27B
| $1.93M | 1.32% |
76,411
-63,495
| -45% | -$1.56M |
2024 Q4
3 quarters
|
|
20
Center Bancorp
CNOB
$1.64B
| $1.88M | 1.29% |
75,799
-6,015
| -7% | -$148K |
2024 Q4
3 quarters
|
|
21
Vaxcyte
PCVX
$10B
| $1.8M | 1.24% |
50,076
+4,577
| +10% | +$152K |
2024 Q4
3 quarters
|
|
22
Eldorado Gold
EGO
$8.24B
| $1.68M | 1.16% |
58,311
+9,557
| +20% | +$225K |
2024 Q4
3 quarters
|
|
23
Equinox Gold
EQX
$12.3B
| $1.6M | 1.1% |
142,393
-6,148
| -4% | -$48.9K |
2024 Q4
3 quarters
|
|
24
NIO
NIO
$7.27B
| $1.57M | 1.08% |
+206,260
| New | +$1.11M |
2025 Q3
0 quarters
|
|
25
Alcoa
AA
$10.5B
| $1.56M | 1.07% |
47,427
+8,182
| +21% | +$254K |
2025 Q1
2 quarters
|
|
Similar funds
WMA
AIA
EFH
Persistent Asset Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Persistent Asset Partners deployed $7.44M of net new capital in Q3 2025, opening 137 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 229,544 shares worth $8.19M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $3.43M trimmed.
- Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
- Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
- Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
- Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
- Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
- Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
- Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.
Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.